Parenteral Drugs (India) Ltd
PDPL

Parenteral Drugs (India) Ltd (PDPL)

₹3.82.7%

Key Stats

₹3.7
Day's Price Range
₹3.8
₹2.5
52-Week Price Range
₹4.65
1 Month Return0 %
3 Month Return-9.76 %
1 Year Return-16.86 %

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 74
-0.12
EPS
Rank 75
₹-41.93
BVPS
Rank 82
₹-264.78
Dividend Yield
Rank 41
ROE
Rank 120
Price To Book Ratio
Rank 63
-0.02
Debt To Asset
Rank 2
2.06

Company Information

Parenteral Drugs India Ltd is an Indiabased pharmaceutical company. The company develops manufactures and markets a range of pharmaceutical products in India. Their products include solid and liquid orals such as antibiotics and antibacterial antiulcerant analgesics/antiinflammatory multivitamins and minerals anxiolyic antiprotozoal anticold anthelmintic antihistaminic muscle relaxant cardiac antidiabetic cough syrup appetite enhancer and injections. The company produces various therapeutic segments of InVitro I V Fluids such as electrolytes antibacterial energy replenisher irrigation solution osmotic diuretic dialysis solution. They also produce 400milligram Ciprofloxacin infusion in 200 milliliter with 5 dextose. Apart from the single dose dispensers the company has also launched multidose eye/ ear drops in plastic containers. The dispensers are made using the formfillseal technology.Parenteral Drugs India Ltd was incorporated in the year 1983 as a private limited company. In the year 1989 the company established their first unit to manufacture I V Fluids in Polypropylene containers with a capacity of 18 lakh bottles per annum. In March 1994 the company was converted into a public limited company. In September 1994 the company came out with a public issue at a premium of Rs 80 aggregating Rs 7.03 crore to partfinance their Rs 8.97crore expansion. During the year 199495 the company set up a joint venture unit in Ukraine for manufacture of a wide range of pharmaceuticals. In addition they set up a unit for the manufacture of I V Fluids at Jalandhar in Punjab. During the year 199798 the company purchased 100 equity of the Parenteral Drugs International Ltd and made it a wholly owned subsidiary of the company. They also purchased 50 equity in Parental Drugs Punjab Ltd. During the year 19992000 the company was awarded ISO 9002 Certification as a symbol of quality products.During the year 200304 the company installed Injections with the production capacity of 516 lakh numbers. During the year 200506 the company increased the production capacity of I V Fluid Transfusion by 45000000 Nos to 120000000 Nos. In addition they set up a plant for manufacturing pharmaceutical products at Baddi in Himachal Pradesh. During the year 200607 the company increased the production capacity of Tablets/ Capsules by 1125000000 Nos Ampoules by 90000000 Nos and Injections 56400000 Nos. During the year 200708 they increased the production capacity of Large Volume by 30000000 Nos and Ampoules by 95000000 Nos.The company has decided to amalgamate two of their group companies namely PFL Holdings Pvt Ltd and Goa Holdings India Pvt Ltd into the company. As a result of this amalgamation their respective subsidiaries namely Punjab Formulations Ltd and Goa Formulations Ltd shall become the wholly owned subsidiaries of the company.
OrganisationParenteral Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals